{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:01:38Z","timestamp":1761894098394},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.clinthera.2005.02.001","type":"journal-article","created":{"date-parts":[[2005,4,7]],"date-time":"2005-04-07T17:39:46Z","timestamp":1112895586000},"page":"166-173","source":"Crossref","is-referenced-by-count":19,"title":["Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: A multicenter, randomized, double-blind, 24-week study"],"prefix":"10.1016","volume":"27","author":[{"given":"Manuel Luque","family":"Otero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nieves Marte","family":"Claros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2005.02.001_bib1","unstructured":"Instituto Nacional de Estadistica. Defunciones segun la Causa de Muerte. Available at: http:\/\/www.ine.es\/inebase\/menu2.html, Accessed March 13, 2004"},{"key":"10.1016\/j.clinthera.2005.02.001_bib2","first-page":"489","article-title":"Hypertension-related mortality and arterial pressure in Spain [in Spanish]","volume":"112","author":"Banegas Banegas","year":"1999","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.clinthera.2005.02.001_bib3","first-page":"458","article-title":"Association of metabolic risk factors and blood pressure in a natural population (Mora de Toledo) [in Spanish]","volume":"17","author":"Almodovar","year":"1996","journal-title":"Aten Primaria"},{"key":"10.1016\/j.clinthera.2005.02.001_bib4","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2337\/diacare.17.11.1247","article-title":"Prevalence of arterial hypertension in diabetic patients before and after the JNC-V","volume":"17","author":"Tarnow","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2005.02.001_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial","volume":"16","author":"Stamler","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2005.02.001_bib6","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2005.02.001_bib7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00004872-200306000-00001","article-title":"2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension","volume":"21","author":"European Society of Hypertension-European Society of Cardiology Guidelines Committee","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.clinthera.2005.02.001_bib8","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2005.02.001_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.amjhyper.2003.07.005","article-title":"Is it time to move to multidrug combinations?","volume":"16","author":"Pool","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.clinthera.2005.02.001_bib10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archinte.155.10.1073","article-title":"Long-term effects of anti hypertensive agents on proteinuria and renal function","volume":"155","author":"Maki","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2005.02.001_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199903043400902","article-title":"Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension","volume":"340","author":"Tuomilehto","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2005.02.001_bib12","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2165\/00003495-200161120-00010","article-title":"Manidipine: A review of its use in hypertension","volume":"61","author":"Cheer","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2005.02.001_bib13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/00005344-200110000-00017","article-title":"Efficacy, tolerability, and impact on quality of life and long-term treatmentwith manidipine or amlodipine in patients with essential hypertension","volume":"38","author":"Zanchetti","year":"2001","journal-title":"J Cardiouasc Pharmacol"},{"key":"10.1016\/j.clinthera.2005.02.001_bib14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/00004872-199510000-00005","article-title":"Calculation of trough:peak ratio of anti hypertensive treatment from ambulatory blood pressure: Methodological aspects","volume":"13","author":"Omboni","year":"1995","journal-title":"J Hypertens"},{"key":"10.1016\/j.clinthera.2005.02.001_bib15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00005344-200006000-00015","article-title":"Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients","volume":"35","author":"Mancia","year":"2000","journal-title":"J Cardiouasc Pharmacol"},{"key":"10.1016\/j.clinthera.2005.02.001_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0168-8227(99)00114-X","article-title":"Delapril versus manidipine in hypertensive therapy to halt the type-2-diabetes-mellitus-associated nephropathy","volume":"47","author":"Shiba","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clinthera.2005.02.001_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2005.02.001_bib18","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/bmj.289.6457.1495","article-title":"Do anti hypertensive drugs precipitate diabetes?","volume":"289","author":"Bengtsson","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.clinthera.2005.02.001_bib19","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/bmj.298.6681.1147","article-title":"Do antihypertensive drugs precipitate diabetes in predisposed men?","volume":"298","author":"Skarfors","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2005.02.001_bib20","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00004872-200211000-00001","article-title":"Antihypertensive treatment in patients with type-2 diabetes mellitus: What guid ance from recent controlled randomized trials?","volume":"20","author":"Zanchetti","year":"2002","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2005.02.001_bib21","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0895-7061(00)00587-2","article-title":"Manidipine has less oedematigenous potential than amlodipine","volume":"13","author":"Fogari","year":"2000","journal-title":"Am J Hypertens"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291805000135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291805000135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T18:22:25Z","timestamp":1548613345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291805000135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0149291805000135"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2005.02.001","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}